Weekly, from one device
Four fixed doses per pen — one injection day a week, six days off.
Zepbound KwikPen / Brand tirzepatide
Zepbound
Weekly brand tirzepatide — for people weighing the KwikPen against the compounded vial on price, prior GLP-1 use, and side effects before they start.
from $279.33/first mo.
FSA & HSA eligibleGLP-1 + GIP receptorsMulti-dose weekly penSix strengths priced
The KwikPen route
One pen. Four weekly doses. No roulette.
Zepbound KwikPen is a single-patient, prefilled multi-dose pen designed to deliver four fixed weekly doses. Your provider selects the strength.
Provider-selected strength
Six strengths from 2.5 mg to 15 mg; escalation follows labeling, history, and tolerance.
Manufacturer packaging, filled through Rebody
Licensed-pharmacy fulfillment instead of calling around during a stockout week.
GLP-1 + GIP
GLP-1 + GIP, in the brand device.
Tirzepatide activates GLP-1 and GIP receptors involved in appetite, fullness, and metabolic signals. The KwikPen wraps that mechanism in commercial manufacturing and labeling-driven dosing.
receptor targets
GLP-1 + GIP — tirzepatide's dual mechanism.
doses per pen
Fixed weekly doses from one single-patient device.
dose strengths
2.5 to 15 mg, each priced on the page.
Routes compared
Brand pen, compounded vial, or daily melt?
All three carry tirzepatide. The KwikPen is the commercial device; the compounded vial costs less and is not FDA-approved; the melt skips needles entirely. Wegovy is the brand-pen comparison — semaglutide, which works on GLP-1 alone.
Zepbound KwikPen
Weekly tirzepatide
Oral Tirzepatide
Wegovy Pen
Compound
Brand tirzepatide
Compounded tirzepatide + glycine/B12
Compounded tirzepatide (GLP‑1 + GIP)
Brand semaglutide
Route + rhythm
Once-weekly prefilled pen
Once-weekly self-injection
Daily melt under the tongue
Once-weekly prefilled pen
Needles + supplies
Multi-dose pen + pen needles
Syringes + sharps container
None
Single-use pens
Starting price
from $558.99 / 28 days
from $199.99 / 28 days
from $234.99 / 30 days
from $404.99 / 28 days
Starting prices reflect the lowest currently available dose; higher doses cost more, and your provider sets the final dose and form.
Rebody Health / Zepbound KwikPen
Zepbound / 28-Day Supply
Six strengths. Six visible prices.
From 2.5 mg to 15 mg, every KwikPen strength is priced before your visit. A provider reviews medications, blood-sugar history, prior GLP-1 use, and contraindications first.
Weekly KwikPenBrand Tirzepatide28-Day Supply
First month with offerfrom$279.33/first mo.
FSA & HSA eligibleUse eligible benefit funds
Split your payment into interest-free installments with Klarna at checkout.
Commercial brand-name KwikPen
Four fixed weekly doses per pen
All six strengths priced up front
Licensed-pharmacy fulfillment
Charged today — ships if prescribed. Individual results vary.
Rx only
Medical details checked
Follow-up access
Before it ships
The pen solves setup. Your history still decides the dose.
Compounding news doesn't change your pen
The KwikPen is the commercial product — whatever happens to compounded availability, brand fulfillment is its own track.
The higher price buys the device
Brand manufacturing, fixed-dose delivery, and labeling-driven escalation are the practical tradeoff against a lower-cost compounded vial.
Prior GLP-1 use shapes the start
Coming from semaglutide or compounded tirzepatide changes your starting strength — tell the provider what dose you were on and how you tolerated it.
Safety & eligibility
Who can — and can't — take this.
Prescription-only brand medication
Zepbound is a commercial brand-name medication fulfilled by a licensed pharmacy. A provider must prescribe before anything ships.
Boxed warning on the label
Zepbound carries a boxed warning. Health history, contraindications, and current medications are walked through during your visit.
Dosing follows labeling
Dose strength and any escalation follow commercial labeling and provider judgment — never a checkout selection.
Independent of the manufacturer
Zepbound® is a registered trademark of Eli Lilly and Company. Rebody Health is an independent telehealth service and is not affiliated with or endorsed by the manufacturer.